Effects of Circuit Training on Cardiopulmonary Fitness in Multi Drug Abusers (NCT07546422) | Clinical Trial Compass
CompletedNot Applicable
Effects of Circuit Training on Cardiopulmonary Fitness in Multi Drug Abusers
Pakistan60 participantsStarted 2025-09-30
Plain-language summary
The aim of this research is to evaluate the effects of circuit training on cardiopulmonary fitness among the different categories of drug abusers. Randomized clinical trial is conducted in registered Drug Rehabilitation Center with Social Welfare Department of Khyber Pakhtunkhwa, Da Haq Awaz (Anti-Drugs Organization), Peshawar. The sample size is 60 participants (n=60). These participants were divided into two groups: Group A (n = 30) and Group B (n = 30). Study duration is of 6 months. Sampling technique applied was Non probability Purposive Sampling technique. Only male participants were included which age was 18-60 years with multi-drugs abusing. Tools used in the study are 6 Minute Walk Test, Step Test-VO2max, Spirometer Testing and Mini-Mental State Examination. Data was analyzed through SPSS 23.
Who can participate
Age range
18 Years – 60 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Participants meeting the below criteria, shall be recruited in the study:
* Those patients will be included who have completed acute detoxification period (15 days of Date of Admission) also the patients who were relapsed after 3 months of treatment and re-admitted.
* Only male participants will be included.
* Age of the participants will be 18 to 60 years old.
* Informed Consent will be taken from subjects or their legal guardians.
* Those participants will be included in the study that has complete relevant medical record (Multi Drug kit Report).
* Elderly drug abusers (Can perform 6 Minute Walk Test without complication)
Exclusion Criteria:
Following participants will be excluded from the study:
* Glaucoma disease or severe mental illness, or a history of epilepsy/seizures.
* Serious systemic disease in the past three months, such as gastrointestinal bleeding, diabetes and hypertension.
* Diagnosed cardiopulmonary disease
* Any neurological complication
* Those patients who having Hepatitis C Virus, HIV \& Hepatitis B Virus will be excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.